Scholars Central

Conference abstractPublished 11 May 2018

Association between HLA-B*15:02 and Oxcarbazepine induced cutaneous adverse reaction: a meta-analysis

Authors: Xiaoling Wang

Capital Medical University, China

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: HLA-B*15:02 has been demonstrated as a key risk factor for carbamazepine (CBZ) induced severe cutaneous adverse reaction (sCAR) especially in Asian population. Oxcarbazepine, a drug that has similar structure of CBZ. However, the HLA-B*15:02 is remained unknown for relationship of OXC induced cADR. Method: 8 studies included for analysis, including 32 sCAR cases, 112 mild cutaneous adverse reaction (mcADR) cases, 281 OXC tolerant control, 946 population control. Result: In tolerant control group, an association was between HLA-B*15:02 genotype and OXC induced sCAR (OR, 18.13; 95% CI, 6.77-48.56), but not in mcADR (OR, 1.43; 95% CI, 0.56-3.64). In population control group, the result is similar, in sCAR (OR, 8.22; 95% CI, 3.03-22.34), in mcADR (OR, 2.06; 95% CI, 0.91-4.67). Discussion: Our study demonstrated that although OXC has a privilege compare to CBZ among sCAR, it might still share the similar genetic risk factor --HLA-B*15:02, on inducing sCAR.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • BylineArticles whose byline prints “Xiaoling Wang”